No Data
No Data
Mizuho Securities Maintains EyePoint Pharmaceuticals(EYPT.US) With Buy Rating
Scotiabank Maintains EyePoint Pharmaceuticals(EYPT.US) With Buy Rating, Maintains Target Price $18
Express News | Chardan Capital Maintains Buy on EyePoint Pharmaceuticals, Maintains $33 Price Target
EyePoint Pharmaceuticals Analyst Ratings
A Quick Look at Today's Ratings for EyePoint Pharmaceuticals(EYPT.US), With a Forecast Between $18 to $45
EyePoint Pharmaceuticals Stock Gains 3% After Positive Phase 2 Trial Results
iluvpoptarts : ty much. I owe you a good joke when you're ready
manukahoney : when will CCTG pump occur? pre market today?
Jaguar8 OP manukahoney : it already started pumping Friday AH
manukahoney Jaguar8 OP : is it too late if i pump today during pre market sir?